Concepedia

Paul H. Fischer

PH

10

Publications

449

Citations

10

H-Index

1982

Active since

Affiliations

University of Wisconsin–Madison(Current)

University of Wisconsin Carbone Cancer Center

William S. Middleton Memorial Veterans Hospital

Paul H. Fischer is an author at University of Wisconsin–Madison specializing in pharmacology, medicine, and oncology.

Top concepts

Publications per year

1982–1990

10

Publications

10

Augmentation of 5-fluorouracil cytotoxicity in human colon cancer cells by dipyridamole.

Jean L. Grem, Paul H. Fischer · PubMed · 1985 · 90 citations

, , +17

Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.

Jean L. Grem, Paul H. Fischer · PubMed · 1986 · 65 citations

, , +15

Enhancement of the sensitivity of human colon cancer cells to growth inhibition by acivicin achieved through inhibition of nucleic acid precursor salvage by dipyridamole.

Paul H. Fischer, Rifat Pamukcu, Gerard Bittner et al. · PubMed · 1984 · 59 citations

, , +14

Augmentation of methotrexate cytotoxicity in human colon cancer cells achieved through inhibition of thymidine salvage by dipyridamole

Timothy J. Van Mouwerik, Cynthia A. Pangallo, James K. V. Willson et al. · Biochemical Pharmacology · 1987 · 56 citations

, , +7

Phase I clinical trial of a combination of dipyridamole and acivicin based upon inhibition of nucleoside salvage.

James K. V. Willson, Paul H. Fischer, Kendra D. Tutsch et al. · PubMed · 1988 · 44 citations

, , +12

Rows per page

1–5 of 10